| 期刊簡介 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Pharmacogenomics & Personalized Medicine LetPub Score 5.8
50 ratings
Rate
Reputation 7.1 Influence 4.7 Speed 7.0 | ||||||||||||||||||||
| 期刊簡稱 | PHARMACOGEN PERS MED | ||||||||||||||||||||
| ISSN | 1178-7066 | ||||||||||||||||||||
| h-index | N.A. | ||||||||||||||||||||
| CiteScore |
| ||||||||||||||||||||
| 自引率 (2023-2024) | 0.00%自引率趨勢 | ||||||||||||||||||||
| 掲載範囲 |
| ||||||||||||||||||||
| 官方網站 | https://www.dovepress.com/pharmacogenomics-and-personalized-medicine-journal | ||||||||||||||||||||
| 在線稿件提交 | https://www.dovepress.com/submit_step_1.php | ||||||||||||||||||||
| 開放訪問 | Yes | ||||||||||||||||||||
| 出版商 | Dove Medical Press | ||||||||||||||||||||
| 主題領域 | Biochemistry, Genetics and Molecular Biology | ||||||||||||||||||||
| 出版國/地區 | New Zealand | ||||||||||||||||||||
| 發行頻率 | |||||||||||||||||||||
| 創刊年 | 0 | ||||||||||||||||||||
| 每年文章數 | 42每年文章數趨勢 | ||||||||||||||||||||
| 黃金OA百分比 | 98.62% | ||||||||||||||||||||
OA Related Info![]() | APC: Yes( USD3300; ) APC waiver:Check Notes Other charges: No Keywords: genomic profiling、genetics、pharmacology、drug metabolism Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | ||||||||||||||||||||
| Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q3
| ||||||||||||||||||||
| 索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||
| 鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1178-7066%5BISSN%5D | ||||||||||||||||||||
| 平均審稿時間 * | 來自出版商的數據: 來自作者的數據: 16 Weeks | ||||||||||||||||||||
| 競爭力 * | 來自作者的數據: | ||||||||||||||||||||
| 參考鏈接 |
| ||||||||||||||||||||
| *所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 | |||||||||||||||||||||
|
|
| |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
| [Pharmacogenomics & Personalized Medicine] 的評論 | 撰寫評論 |
| 作者: 豆豆 領域: 医学 審稿時間: 4.0 month(s) 結果: 修改後接受 撰寫評論 |
2025-09-24 08:40:02 評論於 Under the DOVE brand, the layout fee is $3,300. The review process is conducted at a steady pace, with a waiting time of approximately one month for each stage. The review period is mainly uncertain depending on the response of the reviewers. The time from submission to acceptance is around 4 months. Communication with the editors is smooth, and there is also communication with the Chinese service provider during publication. Suitable for warriors in the four districts and graduate students. |
| 作者: longda 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2022-01-05 20:50:52 評論於 The review process seems to be slow, but the editor accepted the revised version directly without giving any feedback to the reviewer. |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
Contact us